Nobel laureate Akasaki returns home

Nobel laureate Akasaki returns home

TOKYO, Japan - Isamu Akasaki, a Meijo University professor who shared this year's Nobel Prize in Physics, attends a press conference in Tokyo, Japan, on Dec. 12, 2014, after returning from Stockholm, where he attended the award ceremony. He said the Nobel medal is "heavy."

  • Product Code
  • ILEA001211744
  • Registered date
  • 2014/12/12 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2014 Kyodo News
  • Media size
  • 2732 × 3968 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 693.30(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Press conference on the identification of existing drugs in Japan

    Press conference on the identification of existing drugs in Japan

    The photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo taking off his mask for explanation. (March 18, 2020, Yasuda Auditorium, University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
      Press conference on the identification of existing drugs in Japan

      Press conference on the identification of existing drugs in Japan

      Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
        Press conference on the identification of existing drugs in Japan

        Press conference on the identification of existing drugs in Japan

        Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
          Professor Inoue of University of Tokyo, announce the identification of a new coronavirus drug candidate

          Professor Inoue of University of Tokyo, announce the identification of a new coronavirus drug candidate

          Professor Junichiro Inoue and his colleagues at the University of Tokyo's Institute of Medical Science held a press conference on April 18 and announced that they had identified nafamostat. Nafamostat has been used for more than 30 years in Japan, and early clinical trials are expected to be conducted. The clinical research is expected to start by the beginning of April in cooperation with the National Center for Global Health and Medicine and others. When the new corona infects humans, proteins on the surface of the virus and proteins on the surface of human cells bind to each other, causing the outer membrane of the virus to fuse with the membrane of human cells. As a result, ribonucleic acid (RNA), which is the genetic information of the new corona, enters the human cell, and the virus multiplies. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
            Press conference on the identification of existing drugs in Japan

            Press conference on the identification of existing drugs in Japan

            Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
              Press conference on the identification of existing drugs in Japan

              Press conference on the identification of existing drugs in Japan

              Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                Press conference on the identification of existing drugs in Japan

                Press conference on the identification of existing drugs in Japan

                Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, wearing a mask at the press conference. (March 18, 2020, Yasuda Auditorium, University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                  Press conference on the identification of existing drugs in Japan

                  Press conference on the identification of existing drugs in Japan

                  Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                    Akira Yoshino, Honorary Fellow of Asahi Kasei Corporation, at a press conference at the Japan Press Club.

                    Akira Yoshino, Honorary Fellow of Asahi Kasei Corporation, at a press conference at the Japan Press Club.

                    Akira Yoshino, Honorary Fellow of Asahi Kasei Corporation, winner of the 2019 Nobel Prize in Chemistry, held a press conference at the Japan Press Club in Uchisaiwai-cho, Tokyo. Referring to the content of the lecture he gave before the award ceremony in Stockholm, Sweden, he expressed his confidence, saying, "I was able to send a reasonable message to the world on environmental issues. He predicted that innovations that combine many technologies will occur in 25 years, saying, "For example, lithium-ion batteries will be installed in automobiles, and by combining artificial intelligence (AI) and the Internet of Things (IoT), we will have a society of cars that is completely unimaginable today. It will be good for the global environment and the burden on individuals will be about one-seventh of what it is now," he said, describing his vision of the future society. (December 20, 2019, Japan Press Club, Uchisaiwai-cho, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                      Akira Yoshino at a press conference after receiving the Nobel Prize at LivTech.

                      Akira Yoshino at a press conference after receiving the Nobel Prize at LivTech.

                      Akira Yoshino (photo), winner of the 2019 Nobel Prize in Chemistry, visited the Lithium Ion Battery Materials Evaluation Research Center (LivTech, Ikeda City, Osaka Prefecture), where he serves as president, for the first time since the award ceremony on April 18 and reported to about 70 people affiliated with the center. At the meeting, Dr. Yoshino said, "Everyone gathered here first thing in the morning. I gave them chocolates in the shape of Nobel Prize medals with my signature on them," he said with a smile. LivTech is a group of researchers from lithium-ion battery-related companies, researching electrode materials and next-generation all-solid-state batteries. Mr. Yoshino said, "We need to promote the integration of artificial intelligence (AI), the Internet of Things (IoT), and other areas around batteries. LivTech, Ikeda City, Osaka Prefecture, December 18, 2019. Credit: Nikkan Kogyo Shimbun / Kyodo News Images